Rintatolimod Induces Antiviral Activities in Human Pancreatic Cancer Cells: Opening for an Anti-COVID-19 Opportunity in Cancer Patients?

SIMPLE SUMMARY: Specific treatment for COVID-19 infections in cancer patients is lacking while the demand for treatment is increasing. Therefore, we explored the effect of Rintatolimod, a Toll-like receptor 3 (TLR3) agonist, on human epithelial cancerous cells. Our results demonstrated that Rintatol...

Descripción completa

Detalles Bibliográficos
Autores principales: Mustafa, Dana A. M., Saida, Lawlaw, Latifi, Diba, Wismans, Leonoor V., de Koning, Willem, Zeneyedpour, Lona, Luider, Theo M., van den Hoogen, Bernadette, van Eijck, Casper H. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227153/
https://www.ncbi.nlm.nih.gov/pubmed/34207861
http://dx.doi.org/10.3390/cancers13122896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227153/
https://www.ncbi.nlm.nih.gov/pubmed/34207861
http://dx.doi.org/10.3390/cancers13122896

Ejemplares similares